J. Goldman & Co’s Sanofi SNY Stock Holding History

J. Goldman & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.61M	Buy	+75,000	New	+$3.5M	0.11%	229
2022 Q4	–	Sell	-34,500	Closed	-$1.31M	–	480
2022 Q3	$1.31M	Buy	+34,500	New	+$1.54M	0.06%	240

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

J. Goldman & Co's SNY Position: Q3 2024 in Review

J. Goldman & Co sold out of Sanofi (SNY) in Q3 2024, closing a stake of 15,000 shares — an estimated $728K sold.

J. Goldman & Co first reported a position in SNY in Q3 2022 and held it in 2 quarters. The position peaked at $4.57M in Q3 2022. 756 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

J. Goldman & Co reported no remaining Sanofi position as of Q3 2024 after selling out during the quarter.
J. Goldman & Co sold 15,000 Sanofi shares in Q3 2024, an estimated $728K.
J. Goldman & Co first reported a position in Sanofi in Q3 2022 and held it in 2 quarters.
J. Goldman & Co's Sanofi position peaked at $4.57M in Q3 2022.
756 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on J. Goldman & Co's 13F filing for Q3 2024, filed 14 Nov 2024.